Literature DB >> 19508437

Duration of symptom onset to hospital admission and admission to discharge or death in SARS in mainland China: a descriptive study.

Dan Feng1, Na Jia, Li-Qun Fang, Jan Hendrik Richardus, Xiao-Na Han, Wu-Chun Cao, Sake J de Vlas.   

Abstract

OBJECTIVE: To describe and analyse factors associated with the duration of disease onset to hospital admission, admission to discharge and admission to death for severe acute respiratory syndrome (SARS), using the recently developed comprehensive database covering all regions of mainland China, and compare the results within and outside China.
METHODS: The database included all probable 5327 SARS cases, of whom 343 died. Linear regression (uni- and multivariate analysis) was performed for all three durations to test the impact of the following variables: sex, age, occupation, geographic location and period of the SARS epidemic (time since the first case, i.e. 16 November 2002).
RESULTS: The average duration of onset of symptoms to hospital admission was 3.8 days, of admission to discharge for those who survived was 29.7 days, while admission to death for casualties was 17.4 days. Health care workers, patients from Tianjin and patients infected towards the end of the epidemic had the shortest duration of onset to admission. Regarding admission to discharge, particularly young patients and patients from Guangdong had the shortest duration. Older age was the sole factor associated with shorter duration of admission to death.
CONCLUSIONS: The average duration and pattern (with time of epidemic and age) of onset of symptoms to hospital admission of SARS patients in mainland China were comparable to other affected areas. The duration of hospital admission to discharge was shorter than elsewhere, possibly because of different hospitalisation policies. The duration of hospital admission to death in mainland China, however, appeared to be shorter than in other areas, which is in striking contrast to the much lower case fatality in mainland China.

Entities:  

Mesh:

Year:  2009        PMID: 19508437     DOI: 10.1111/j.1365-3156.2008.02188.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  15 in total

Review 1.  Antiviral performance of graphene-based materials with emphasis on COVID-19: A review.

Authors:  Tahereh Seifi; Ali Reza Kamali
Journal:  Med Drug Discov       Date:  2021-05-25

2.  Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China.

Authors:  Weier Wang; Jianming Tang; Fangqiang Wei
Journal:  J Med Virol       Date:  2020-02-12       Impact factor: 2.327

3.  What we have learnt from the SARS epdemics in mainland China?

Authors:  Wuchun Cao; Liqun Fang; Dan Xiao
Journal:  Glob Health J       Date:  2019-09-28

Review 4.  The severe acute respiratory syndrome epidemic in mainland China dissected.

Authors:  Wu-Chun Cao; Sake J de Vlas; Jan Hendrik Richardus
Journal:  Infect Dis Rep       Date:  2011-02-18

Review 5.  Risk of MERS importation and onward transmission: a systematic review and analysis of cases reported to WHO.

Authors:  Chiara Poletto; Pierre-Yves Boëlle; Vittoria Colizza
Journal:  BMC Infect Dis       Date:  2016-08-25       Impact factor: 3.090

6.  The SARS epidemic in mainland China: bringing together all epidemiological data.

Authors:  Dan Feng; Sake J de Vlas; Li-Qun Fang; Xiao-Na Han; Wen-Juan Zhao; Shen Sheng; Hong Yang; Zhong-Wei Jia; Jan Hendrik Richardus; Wu-Chun Cao
Journal:  Trop Med Int Health       Date:  2009-06-05       Impact factor: 2.622

Review 7.  2019 novel coronavirus (2019-nCoV) outbreak: A new challenge.

Authors:  Tommaso Lupia; Silvia Scabini; Simone Mornese Pinna; Giovanni Di Perri; Francesco Giuseppe De Rosa; Silvia Corcione
Journal:  J Glob Antimicrob Resist       Date:  2020-03-07       Impact factor: 4.035

8.  Documenting the SARS epidemic in mainland China.

Authors:  Sake J de Vlas; Wu-Chun Cao; Jan Hendrik Richardus
Journal:  Trop Med Int Health       Date:  2009-11       Impact factor: 2.622

Review 9.  Clinical characteristics of COVID-19 in children: Are they similar to those of SARS?

Authors:  Char Leung
Journal:  Pediatr Pulmonol       Date:  2020-05-27

10.  Comorbidities and Factors Determining Medical Expenses and Length of Stay for Admitted COVID-19 Patients in Korea.

Authors:  Su Yeon Jang; Jeong-Yeon Seon; Seung Heon Lee; In-Hwan Oh; Seok-Jun Yoon; So-Youn Park
Journal:  Risk Manag Healthc Policy       Date:  2021-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.